Data is finally out! median follow-up of 12.1 months, PFS was superior in the N-AVD arm [HR 0.48, 99% CI 0.27-0.87) 1y PFS: N-AVD: 94% BV-AVD: 86%

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL ashpublications.org/blood/article-… #leusm

Great paper by my dear friend. So proud of you and your work.

Foto de graduación de residentes de hematología de adultos y pediatría del hospital Universitario “Dr. Jose E. González UANL”

Early results from the bispecific antibody monotherapy epcoritamab show promising outcomes for those with relapsed or refractory high-risk CLL. bit.ly/4iGKF3l

¿Por qué hay gente que pisa Milán y no vuelve igual? No es un viaje. Es una puta lección de belleza. Te muestro 20 razones por las que esta ciudad te deja sin defensa: 🧵👇

My best friend just published this. Great job Michelle🩸 couldn’t be prouder. 🫶🏾 Go read it, you all!

Hoy en la unidad de investigación de trombosis y hemostasia, celebramos el cumpleaños de nuestro querido maestro, el dr Majluf. Un honor aprender de él y una dicha tenerlo otro año más.

New publication🚨 Here we synthethized available evidence on the use of low-doses of nivolumab for r/r HL, an alternative not-so-rarely used in LMICs Perla Colunga ascopubs.org/doi/pdf/10.120…

Navigating new options in #CLL care? Join us and PeerView at #ASCO25 for an interactive TownHall featuring expert insights on BTK inhibitors, CAR-T, and personalized strategies! Learn more at bit.ly/CLL-25T Nitin Jain Krish Patel Meghan Thompson

Working with hector has been a once in a lifetime experience, watching him grow as a doctor and transform into a hematology rising star.

2025 Merkin Prize = earned. ❤️ Honoring the science behind CAR T-cell therapy—and the people who made it possible: 🎉 Pictured: Dr. Carl June, Penn 🎉 Pictured: Dr. Michel Sadelain, Columbia University 🎉 Dr. Isabelle Riviere, Memorial Sloan Kettering Cancer Center 🎉 Dr. Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉, Penn We backed early

Pathogenesis of antiphospholipid syndrome (APS). nejm.org/doi/full/10.10…

ELEVATED VITAMIN B12 High vitamin B12? 🧪 Unlike deficiency, elevated B12 usually isn’t about diet or supplements. It’s often a marker of disease. ... but no consensus on whether/how to investigate! See: thebloodproject.com/elevated-vitam…

Not everything in hematology is about malignancy, so glad I can learn about thrombosis and hemostasia with this incredible team led by the great Dr Majluf.